Tanner Pharma
Charlotte, North Carolina, United States · Biotechnology, Health Care, Pharmaceutical
Tanner Pharma is a global provider of access to specialized medicines. They focus on expanding patient access to innovative therapeutics through collaboration and compliance with regulatory standards. Their initiatives support patients with advanced solid tumors by providing access to critical treatments before regulatory approval. The company operates through Named Patient Programs to meet urgent
Key facts
- Headquarters
- Charlotte, North Carolina, United States
- Employees
- 97
- Industries
- Biotechnology, Health Care, Pharmaceutical
- Status
- Private
- Website
- tannerpharma.com
- Company page
Recent activity at Tanner Pharma
Leadership
- Lee Holmes, Innovative Medicine Specialist
- Katie Smoot, Evp Business Operations
- Steve Scalia, Working With the Best Pharma Services Team
- Breanna Floyd, Finance, Planning and Analysis Staff
- John Roberts, Led Organizations In Bringing Together Financial
- Maryori A., Evp of Tanner CTS Supply & Tanner Gap
- Isabella Petruccelli, Involved In Biopharmaceutical Industry
- Claudia Beltran, Global Technical Operations Manager
- Lindsey Paternoster, Communications Professional
- Lorena M., Sales and Business Development Professional
- Derek Murphy, Sales Executive
Verified email and direct lines for Tanner Pharma’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Tanner Pharma in the news
- Tanner Pharma Group and Biodexa Launch Global Early Access Program for FAP Patients - Business Wire (Mar 31, 2026)
- Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group - Yahoo Finance (Mar 23, 2026)
- Tanner Pharma Group Expands US Operations with New Facility in Charlotte, NC - Business Wire (Apr 22, 2025)
- Elevar Therapeutics and Tanner Pharma Group Announce Launch of Global Named Patient Program to Provide Access to Apealea® (paclitaxel micellar) - PR Newswire (Dec 01, 2020)
- Tanner Pharma Group and UCB Pharma Initiate Partnership for Epilepsy Program in Southeast Asia - Business Wire (Oct 01, 2025)
- Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus - Business Wire (Dec 12, 2024)
- ORPHELIA Pharma Selects Tanner Pharma Group to Initiate Named Patient Program for KIMOZO® (temozolomide) in European Countries - Business Wire (Apr 18, 2023)
Companies similar to Tanner Pharma
- Journey Therapeutics · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Juvisé Pharmaceuticals · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Nimbus Therapeutics · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Timberlyne Therapeutics · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Pelthos Therapeutics · Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Tanner Pharma: questions and answers
What does Tanner Pharma do?
Tanner Pharma is a global provider of access to specialized medicines. They focus on expanding patient access to innovative therapeutics through collaboration and compliance with regulatory standards. Their initiatives support patients with advanced solid tumors by providing access to critical treatments before regulatory approval. The company operates through Named Patient Programs to meet urgent
Where is Tanner Pharma headquartered?
Tanner Pharma is headquartered in Charlotte, North Carolina, United States.
How many employees does Tanner Pharma have?
Tanner Pharma has about 97 employees.
What is the latest news on Tanner Pharma?
On Dec 12, 2024, Tanner Pharma announces partnership with Agenus to expand global access to botensilimab and balstilimab through a Named Patient Program.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy